Impact of Strain Competition on Bacterial Resistance in Immunocompromised Populations

Antibiotics
Ashley A DeNegreNina H Fefferman

Abstract

Despite the risk of emerging drug resistance that occurs with the frequent use of antimicrobial agents, targeted and prophylactic antibiotics have been considered crucial to opportunistic infection management among the HIV/AIDS-immunocompromised. As we recently demonstrated, the disrupted selective pressures that occur in AIDS-prevalent host populations increase the probability of novel emergence. This effect is concerning, given that bacterial strains unresponsive to first-line antibiotics can be particularly dangerous to hosts whose immune response is insufficient to fight infection in the absence of antibiotic support. While greater host susceptibility within a highly immunocompromised population may offer a fitness advantage to drug-resistant bacterial strains, this advantage could be mitigated by increased morbidity and mortality among the AIDS-immunocompromised. Using a Susceptible-Exposed-Infectious-Recovered (SEIR) epidemiological model parameterized to reflect conditions in an AIDS-prevalent host population, we examine the evolutionary relationship between drug-sensitive and -resistant strains of Mycobacterium tuberculosis. We explore this relationship when the fitness of the resistant strain is varied relative to that...Continue Reading

References

Aug 21, 1992·Science·H C Neu
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·K C StoneJ D Crapo
Aug 3, 1999·Antimicrobial Agents and Chemotherapy·O J BillingtonS H Gillespie
Jan 29, 2000·Science·D J EarnB T Grenfell
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C Dye, B G Williams
Oct 29, 2000·The Pediatric Infectious Disease Journal·S B Levy
May 5, 2001·International Journal of Antimicrobial Agents·M KolárT Látal
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kent A Sepkowitz
Jul 19, 2002·Proceedings. Biological Sciences·C Dye, M A Espinal
Oct 25, 2002·Emerging Infectious Diseases·Colin W ShepardUNKNOWN CDC Adverse Events Working Group
Dec 31, 2002·The Lancet Infectious Diseases·Ted CohenMegan Murray
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
Jun 3, 2005·Pediatrics·Sheldon WinnickDavid Toll
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Dec 23, 2006·Journal of the American Academy of Nurse Practitioners·Barbara S Aronson
Apr 6, 2007·Journal of General Internal Medicine·Becky A BriesacherStephen B Soumerai
Apr 24, 2008·JAMA : the Journal of the American Medical Association·Jeanne M MaddenStephen B Soumerai
Feb 3, 2009·Nature Medicine·Wendy P GillDavid R Sherman
Sep 29, 2009·Trends in Ecology & Evolution·Pablo M Beldomenico, Michael Begon
May 27, 2010·AIDS·Kate BuchaczUNKNOWN HOPS Investigators
Mar 11, 2011·Mayo Clinic Proceedings·Marie T Brown, Jennifer K Bussell
Mar 26, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Laura Freire-MoranUNKNOWN ECDC-EMA Working Group
Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Euphemia L SibandaFrances M Cowan
Jul 5, 2011·FEMS Microbiology Reviews·Rafael Cantón, María-Isabel Morosini
Aug 16, 2011·Virology Journal·Muhammad Z YousafUsman A Ashfaq
Jan 21, 2012·Emerging Infectious Diseases·Elisabeth Sanchez-PadillaMaryline Bonnet
Apr 12, 2012·BMJ : British Medical Journal·Ramanan Laxminarayan, David L Heymann
Jun 19, 2012·AIDS·Kevin M De CockJames W Curran
Nov 7, 2012·International Journal of Antimicrobial Agents·António Teixeira RodriguesMaria Teresa Herdeiro
Oct 22, 2013·PloS One·George T BicegoJessica Justman
Oct 25, 2013·Lancet·Steven G DeeksDiane V Havlir
Nov 21, 2013·The Lancet Infectious Diseases·Ramanan LaxminarayanOtto Cars

❮ Previous
Next ❯

Citations

Apr 29, 2020·Antibiotics·Rosa Alduina

❮ Previous
Next ❯

Software Mentioned

Wolfram Mathematica

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.